ROCHE HOLDING LTD (RHHBY)
Clinical trial NCT00382148 updates: 1. completion date: not set → 2008-06-28 2. primary completion date: 2008-06-01 → 2008-06-28 3. enrollment: 10 → 11 participants
ABBVIE INC. (ABBV)
Clinical trial NCT06953960: enrollment: 130 → 199 participants.
TARSUS PHARMACEUTICALS, INC. (TARS)
Clinical trial NCT06687538 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-05-30 3. enrollment type: ESTIMATED → ACTUAL
NATERA, INC. (NTRA)
Clinical trial NCT05837663 updates: 1. completion date: 2027-12-01 → 2028-12-01 2. primary completion date: 2026-11-01 → 2027-11-01
MERCK & CO., INC. (MRK)
Clinical trial NCT07348237 updates: 1. completion date: 2026-08-18 → 2026-07-20 2. primary completion date: 2026-08-18 → 2026-07-20
VIA PHARMACEUTICALS, INC. (VIAP)
Clinical trial NCT06717308: collaborators added: All South Bay Footcare, Absolute Medical Center, LLC, Vital Medical Research, LLC, Eazy Foot & Ankle.
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI)
Clinical trial NCT05324943: enrollment: 6 → 10 participants.
BANK OF AMERICA CORP /DE/ (BAC)
ROCHE HOLDING LTD (RHHBY)
Clinical trial NCT05681039: status: RECRUITING → ACTIVE_NOT_RECRUITING.
NOVARTIS AG (NVSEF)
Clinical trial NCT07357727: start date: 2026-05-15 → 2026-05-27.
GENMAB A/S (GMAB)
Clinical trial NCT04623541: enrollment: 195 → 194 participants.
BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT03771859 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2025-12-30 → 2025-12-09 3. primary completion date: 2025-12-30 → 2025-12-09
GUARDANT HEALTH, INC. (GH)
Clinical trial NCT07436637: start date: 2026-05-30 → 2026-06-30.
ASTRAZENECA PLC (AZN)
Clinical trial NCT05952024 updates: 1. completion date: 2027-08-24 → 2029-04-22 2. primary completion date: 2027-08-24 → 2029-04-22
BAYER A.G. (BAYZF)
Clinical trial NCT05348733 updates: 1. completion date: 2026-12-15 → 2027-12-15 2. primary completion date: 2026-09-30 → 2027-09-01